Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (6MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-543843
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.54384
Zusammenfassung
Despite the advancement in drug discovery for cancer therapy, drug repurposing remains an exceptional opportunistic strategy. This approach offers many advantages (faster, safer, and cheaper drugs) typically needed to overcome increased challenges, i.e., side effects, resistance, and costs associated with cancer therapy. However, not all drug classes suit a patient’s condition or long-time use. ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags